BioXconomy is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Events
Advertise
Stay Updated
Stay Updated
Investment
Related Topics
VC/PE
Seed Funding
IPOs
Recent in
Investment
See All
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
by
Millie Nelson
Feb 17, 2025
6 Min Read
Clock with the words timing is everything in red
Investment
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
by
Millie Nelson
Feb 14, 2025
1 Min Read
Innovation
Related Topics
Hubs
Academic Research
R&D Technology
Recent in
Innovation
See All
headshot of Janeé Pelletier, chief marketing officer at Learning Undefeated.
Partnering
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
by
Millie Nelson
Feb 6, 2025
2 Min Read
Asian currency
Investment
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
by
Millie Nelson
Feb 3, 2025
4 Min Read
Partnering
Related Topics
Licensing
M&A
Deals
Best Practices
Recent in
Partnering
See All
Clock with the words timing is everything in red
Investment
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
by
Millie Nelson
Feb 14, 2025
1 Min Read
headshot of Janeé Pelletier, chief marketing officer at Learning Undefeated.
Partnering
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
by
Millie Nelson
Feb 6, 2025
2 Min Read
Business Strategy
Related Topics
Scaling/Commercialization
Growth Strategy
ESG
Outsourcing
Legal
Recent in
Business Strategy
See All
Steven fuller with a yellow background - Race in STEM founder and Director
ESG
Race in STEM: Countering the ugly truth of bias in life sciences
Race in STEM: Countering the ugly truth of bias in life sciences
by
Millie Nelson
Feb 12, 2025
8 Min Read
Hot keys for business analysis and commercialization
Scaling/Commercialization
A clear commercialization strategy is imperative for success, says expert
A clear commercialization strategy is imperative for success, says expert
by
Lisa Henderson
Jan 27, 2025
3 Min Read
Home
Jonathan Smith
Jonathan Smith
Latest from Jonathan Smith
2025 wooden blocks
Investment
Takeovers, Trump, and trends: how biopharma is likely to shift this year
Takeovers, Trump, and trends: how biopharma is shifting this year
by
Jonathan Smith
Jan 1, 2025
5 Min Read
Sean Knight, Senior Director, Business Development, Simtra BioPharma Solutions, discusses the company’s expansion plans.
Sponsored Content
Going to Market with Simtra BioPharma Solutions
Going to Market with Simtra BioPharma Solutions
by
BIO-Europe 2024
Dec 19, 2024
3 Min View
All from Jonathan Smith
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech
Dec 18, 2024
|
3 Min View
by
BIO-Europe 2024
Sponsored Content
NorthX Biologics is Beyond CDMO
NorthX Biologics is Beyond CDMO
Dec 18, 2024
|
4 Min View
by
BIO-Europe 2024
Sponsored Content
Tips toward a better presentation
Tips Toward a Better Presentation
Dec 18, 2024
|
3 Min View
by
BIO-Europe 2024
Sponsored Content
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Dec 18, 2024
|
9 Min View
by
BIO-Europe 2024
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Dec 18, 2024
|
8 Min View
by
BIO-Europe 2024
Investment
Megadeals continued amid sluggish investments and M&A in 2024
Megadeals continued amid sluggish investments and M&A in 2024
Dec 18, 2024
|
2 Min Read
by
Jonathan Smith
Sponsored Content
Why are DMCs Important to Clinical Development?
Why are DMCs Important to Clinical Development?
Dec 17, 2024
|
4 Min View
by
BIO-Europe 2024
Sponsored Content
Scale Up and Boost Your Viral Vector Production
Scale Up and Boost Your Viral Vector Production
Dec 17, 2024
|
4 Min View
by
BIO-Europe 2024
BIO-EUROPE COVERAGE
Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech
Latest
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Clock with the words timing is everything in red
Investment
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
Steven fuller with a yellow background - Race in STEM founder and Director
ESG
Race in STEM: Countering the ugly truth of bias in life sciences
Race in STEM: Countering the ugly truth of bias in life sciences
BIO-Europe Spring banner Milan Italy
Mar 17 - Mar 19, 2025
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated